| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.14.11.1741 |
| P698 | PubMed publication ID | 7947598 |
| P50 | author | Maurizio Margaglione | Q42638173 |
| Elvira Grandone | Q62491224 | ||
| P2093 | author name string | M Mancini | |
| S Panico | |||
| G Di Minno | |||
| E Celentano | |||
| G Cappucci | |||
| P Simone | |||
| M Grilli | |||
| G Vecchione | |||
| P433 | issue | 11 | |
| P921 | main subject | plasminogen | Q107129060 |
| P304 | page(s) | 1741-1745 | |
| P577 | publication date | 1994-11-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke | |
| P478 | volume | 14 |
| Q89686770 | A comparative pharmacogenomic analysis of three classic TCM prescriptions for coronary heart disease based on molecular network modeling |
| Q46707808 | An Insertion/Deletion polymorphism in the promoter region of the plasminogen activator inhibitor-1 gene is associated with plasma levels but not with stroke risk in the elderly |
| Q35023612 | Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets |
| Q36832898 | Cell-derived microparticles and exosomes in neuroinflammatory disorders |
| Q30826562 | Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats |
| Q73025879 | Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta |
| Q30999425 | Epistatic interactions in genetic regulation of t-PA and PAI-1 levels in a Ghanaian population. |
| Q37274431 | Hematological diseases and stroke |
| Q59590875 | Hyperbaric oxygen therapy prevents coagulation disorders in an experimental model of multiple organ failure syndrome |
| Q73028153 | Increased plasma plasminogen activator inhibitor-1 levels: a possible marker of hypertensive target organ damage |
| Q34025555 | Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillation |
| Q74214766 | Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease. a prospective study |
| Q52535925 | Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries. |
| Q71778269 | Plasminogen activator levels are influenced by location and varicosity in greater saphenous vein |
| Q47822581 | Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. |
| Q46059099 | Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy |
| Q83306169 | The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction |
| Q42465243 | The effect of number of days in culture and plasminogen activator inhibitor-1 (PAI-1) 4G/5G genotype on PAI-1 antigen release by cultured human umbilical vein endothelial cells |
| Q35156068 | The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones |
| Q31899830 | The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group |
| Q35923428 | Tissue plasminogen activator and glial function |
| Q35109940 | Update on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients. |
| Q47305359 | Vasoconstrictively acting AT1R A1166C and NOS3 4/5 polymorphisms in recurrent spontaneous abortions (RSA). |
| Q35936630 | Zymographic evaluation of plasminogen activators and plasminogen activator inhibitors. |
Search more.